Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Mouton

Showing results (61-70 of 392) with videos related to

Pageof 40
Sort By:
Antimicrobial Agents and Chemotherapy|February 22, 2018
A New Marker of Echinocandin Activity in an <i>In Vitro</i> Pharmacokinetic/Pharmacodynamic Model Correlates with an Animal Model of Aspergillus fumigatus InfectionJoseph Meletiadis, Maria Siopi, Athanassios Tsakris, et al.
Seminars in Fetal & Neonatal Medicine|February 11, 2005
New dosing strategies for antibacterial agents in the neonateMatthijs de Hoog, Johan W Mouton, John N van den Anker
The Thoracic and Cardiovascular Surgeon|December 24, 1997
Long-term follow-up of patients with operative stabilisation of a flail chestW Mouton, D Lardinois, M Furrer, et al.
The Journal of Antimicrobial Chemotherapy|June 10, 2016
Pharmacodynamics and differential activity of nitrofurantoin against ESBL-positive pathogens involved in urinary tract infectionsFiona Fransen, Maria J B Melchers, Joseph Meletiadis, et al.
American Journal of Respiratory and Critical Care Medicine|October 17, 2013
Continuous infusion of amphotericin B deoxycholate for the treatment of life-threatening Candida infectionsSeyedmojtaba Seyedmousavi, Johan W Mouton, Paul E Verweij, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 30, 1998
[Gentamicin dosing regimen for neonates: once daily]M De Hoog, J W Mouton, J N van Den Anker
Clinical Pharmacokinetics|May 14, 2004
Vancomycin: pharmacokinetics and administration regimens in neonatesMatthijs de Hoog, Johan W Mouton, John N van den Anker
Schweizerische Medizinische Wochenschrift|February 28, 1998
[Surgical aspects of mycobacterioses. Evolution during the last 20 years]D Lardinois, M Furrer, W Mouton, et al.
The Journal of Antimicrobial Chemotherapy|September 2, 2021
Pharmacokinetic/pharmacodynamic analysis of oral fosfomycin against Enterobacterales, Pseudomonas aeruginosa and Enterococcus spp. in an in vitro bladder infection model: impact on clinical breakpointsIain J Abbott, Johan W Mouton, Anton Y Peleg, et al.
Antimicrobial Agents and Chemotherapy|January 14, 2015
The strength of synergistic interaction between posaconazole and caspofungin depends on the underlying azole resistance mechanism of Aspergillus fumigatusEleftheria Mavridou, Joseph Meletiadis, Antony Rijs, et al.
Pageof 40

Showing results (61-70 of 392) with videos related to

Sort By:
Pageof 40
Antimicrobial Agents and Chemotherapy|February 22, 2018
A New Marker of Echinocandin Activity in an <i>In Vitro</i> Pharmacokinetic/Pharmacodynamic Model Correlates with an Animal Model of Aspergillus fumigatus InfectionJoseph Meletiadis, Maria Siopi, Athanassios Tsakris, et al.
Seminars in Fetal & Neonatal Medicine|February 11, 2005
New dosing strategies for antibacterial agents in the neonateMatthijs de Hoog, Johan W Mouton, John N van den Anker
The Thoracic and Cardiovascular Surgeon|December 24, 1997
Long-term follow-up of patients with operative stabilisation of a flail chestW Mouton, D Lardinois, M Furrer, et al.
The Journal of Antimicrobial Chemotherapy|June 10, 2016
Pharmacodynamics and differential activity of nitrofurantoin against ESBL-positive pathogens involved in urinary tract infectionsFiona Fransen, Maria J B Melchers, Joseph Meletiadis, et al.
American Journal of Respiratory and Critical Care Medicine|October 17, 2013
Continuous infusion of amphotericin B deoxycholate for the treatment of life-threatening Candida infectionsSeyedmojtaba Seyedmousavi, Johan W Mouton, Paul E Verweij, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 30, 1998
[Gentamicin dosing regimen for neonates: once daily]M De Hoog, J W Mouton, J N van Den Anker
Clinical Pharmacokinetics|May 14, 2004
Vancomycin: pharmacokinetics and administration regimens in neonatesMatthijs de Hoog, Johan W Mouton, John N van den Anker
Schweizerische Medizinische Wochenschrift|February 28, 1998
[Surgical aspects of mycobacterioses. Evolution during the last 20 years]D Lardinois, M Furrer, W Mouton, et al.
The Journal of Antimicrobial Chemotherapy|September 2, 2021
Pharmacokinetic/pharmacodynamic analysis of oral fosfomycin against Enterobacterales, Pseudomonas aeruginosa and Enterococcus spp. in an in vitro bladder infection model: impact on clinical breakpointsIain J Abbott, Johan W Mouton, Anton Y Peleg, et al.
Antimicrobial Agents and Chemotherapy|January 14, 2015
The strength of synergistic interaction between posaconazole and caspofungin depends on the underlying azole resistance mechanism of Aspergillus fumigatusEleftheria Mavridou, Joseph Meletiadis, Antony Rijs, et al.
Pageof 40